Matthew K. Fust - Director at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Matthew K. Fust - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Matthew K. Fust for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 22.8K $1.02M $44.75 Sep 26, 2025 Direct
Stock Option (Right to Buy) 2.09K Sep 26, 2025 Direct Common Stock

Transactions reported by Matthew K. Fust for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.